Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma
Clinical trial NCT02971319 · COMPLETED
Trial details
- NCT number
- NCT02971319
- Sponsor
- Proactina S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-11-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.